HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Avner Reshef Selected Research

Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)

1/2019Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
11/2017Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.
9/2017Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.
1/2017Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.
5/2015Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
8/2010Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks.
10/2009Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Avner Reshef Research Topics

Disease

21Hereditary Angioedemas
05/2024 - 12/2008
10Angioedema
01/2022 - 10/2009
4Hypersensitivity (Allergy)
01/2019 - 04/2016
3Edema (Dropsy)
08/2010 - 12/2008
2Anaphylaxis (Anaphylactic Shock)
09/2017 - 02/2014
1Fatigue
09/2017
1Headache (Headaches)
09/2017
1Injection Site Reaction
12/2011
1Vomiting
10/2009
1Body Weight (Weight, Body)
10/2009

Drug/Important Bio-Agent (IBA)

7Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
01/2019 - 10/2009
5icatibantIBA
01/2021 - 08/2010
4BradykininIBA
01/2022 - 12/2008
3Factor XIIa (Coagulation Factor XIIa)IBA
05/2024 - 01/2022
3Monoclonal AntibodiesIBA
05/2024 - 01/2022
2Immunoglobulins (Immunoglobulin)IBA
05/2024 - 01/2022
2Neutralizing AntibodiesIBA
01/2019 - 02/2014
2AntibodiesIBA
09/2017 - 07/2017
1A-factor (Streptomyces)IBA
01/2023
1Factor XII (Hageman Factor)IBA
01/2022
1berotralstatIBA
06/2021
1Biomarkers (Surrogate Marker)IBA
06/2021
1Plasma KallikreinIBA
06/2021
1Anti-Bacterial Agents (Antibiotics)IBA
04/2016
1diphenylthiosulfinate (DPTS)IBA
04/2016
1LactamsIBA
04/2016
12,5-dichloro-4-bromophenol (B 2)IBA
12/2011
1Tranexamic Acid (AMCA)FDA Link
08/2010
1Bradykinin Receptor AntagonistsIBA
08/2010
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2009
1Bradykinin Receptors (Bradykinin Receptor)IBA
08/2009

Therapy/Procedure

8Therapeutics
01/2023 - 07/2010
1Aftercare (After-Treatment)
10/2009